0000899243-21-024214.txt : 20210616
0000899243-21-024214.hdr.sgml : 20210616
20210616181334
ACCESSION NUMBER: 0000899243-21-024214
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210616
DATE AS OF CHANGE: 20210616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dierks Jeffrey
CENTRAL INDEX KEY: 0001821102
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39450
FILM NUMBER: 211022661
MAIL ADDRESS:
STREET 1: 630 W. GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc.
CENTRAL INDEX KEY: 0001802665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822279923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 630 W GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
BUSINESS PHONE: (484) 539-9800
MAIL ADDRESS:
STREET 1: 630 W GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-15
0
0001802665
Harmony Biosciences Holdings, Inc.
HRMY
0001821102
Dierks Jeffrey
630 W. GERMANTOWN PIKE, SUITE 215
PLYMOUTH MEETING
PA
19462
0
1
0
0
Chief Commercial Officer
Common Stock
2021-06-15
4
M
0
15000
8.22
A
15000
D
Common Stock
2021-06-15
4
S
0
15000
31.3204
D
0
D
Stock Option
8.22
2021-06-15
4
M
0
15000
0.00
D
2027-10-02
Common Stock
15000
33692
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.96 to $31.73. The reporting person undertakes to provide the issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock option is currently vested with respect to 20,707 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 2, 2021.
/s/ Christian Ulrich, Attorney-in-fact for Jeffrey Dierks
2021-06-16